756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin

por Adamsick, Meagan L, Gandhi, Ronak G, Steiger, Samantha N, Bidell, Monique R, Nelson, Sandra B, Ard, Kevin L, Elshaboury, Ramy H
Publicado 2019

Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience

por Brownell, Lauren E., Adamsick, Meagan L., McCreary, Erin K., Vanderloo, Joshua P., Ernst, Erika J., Jackson, Emily R., Schulz, Lucas T
Publicado 2020

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients

por Williams, Kelsey N, Elshaboury, Ramy H, Letourneau, Alyssa R, Adamsick, Meagan L, Gandhi, Ronak G, Paras, Molly L, Bidell, Monique R
Publicado 2020

1482. Local validation of the drug resistance in pneumonia clinical prediction score at a large academic medical center and a community hospital

por Reinhard, Jennifer L, Elshaboury, Ramy H, Hayes, Bryan D, Mallada, Jason, Paras, Molly L, Bidell, Monique R, Adamsick, Meagan L, Gandhi, Ronak G
Publicado 2020

Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period

por Elshaboury, Ramy H., Monk, Miranda M., Bebell, Lisa M., Bidell, Monique R., Adamsick, Meagan L., Gandhi, Ronak G., Paras, Molly L., Hohmann, Elizabeth L., Letourneau, Alyssa R.
Publicado 2021

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

por Atallah, Natalie J., Warren, Hailey M., Roberts, Matthew B., Elshaboury, Ramy H., Bidell, Monique R., Gandhi, Ronak G., Adamsick, Meagan, Ibrahim, Maryam K., Sood, Rupali, Bou Zein Eddine, Savo, Cobler-Lichter, Matthew J., Alexander, Natalie J., Timmer, Kyle D., Atallah, Christine J., Viens, Adam L., Panossian, Vahe S., Scherer, Allison K., Proctor, Teddie, Smartt, Sherrie, Letourneau, Alyssa R., Paras, Molly L., Johannes, Sascha, Wiemer, Jan, Mansour, Michael K.
Publicado 2022